All posts by: Michael Zand

About Michael Zand

UNREGULATED STEM CELL CLINICS IN THE US – LWW Journals

Continue reading

2015-10-22

Daily Mail

UNREGULATED STEM CELL CLINICS IN THE US
LWW Journals
The International Society for Stem Cell Research provides clear, consumer-friendly explanations of the current state of stem cell science in a downloadable patient handbook, including a glossary of terms, how to assess whether a treatment is legitimate
Your baby’s umbilical cord could treat future Alzheimer’s and cancerDaily Mail
Mesoblast limited Upgraded by Zacks to Hold (MBLTY)Financial Wisdom Works

all 5 news articles »

Continue reading

2015-10-22

Stem cell research opens door to new diabetes treatments
Medical Xpress
Type 1 diabetes is a chronic insulin deficiency condition that is triggered by massive destruction of beta cells – pancreatic cells that normally produce insulin. This type of diabetes can be diagnosed at all ages but is the most frequent form when

Continue reading

2015-10-22

Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II
Benzinga
In the article, titled, Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy, the use of BioLife’s clinical grade CryoStor freeze media was disclosed. Details of the

and more »

Continue reading

2015-10-22

Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II
MarketWatch
In July 2015, Frost & Sullivan forecasted that the stem cell therapy market is expected to be worth $40 billion by 2020 and $180 billion by 2030. The Global Healthcare Cold Chain Logistics Market Report & Forecast published by the IMARC Group forecasts …

and more »